thromboprophylaxis

thromboprophylaxis

(throm″bō-prō″fĭ-lak′sĭs) [ thrombo- + prophylaxis]
Any preventive measure or medication that reduces the likelihood of the formation of blood clots.
thromboprophylactic (throm″bō-prō″fĭ-lak′tik), adjective
References in periodicals archive ?
Health care professionals are advised to consider the benefits and risks before neuraxial intervention in patients anticoagulated or to be anticoagulated for thromboprophylaxis.
opioids, sedative antihistamines and neuroleptics) 7 Thromboprophylaxis Given thromboprophylaxis; low-molecular-weight heparin and compression stockings 8 Antibiotic prophylaxis Given antibiotic prophylaxis before skin incision 9 Regional anaesthesia Anaesthetic procedure that allows rapid awakening, adequate analgesia and patient recovery.
[4,8] Despite the unfavourable figures and formalised recommendations, thromboprophylaxis is found to be under-prescribed.
SAN DIEGO -- In critically ill patients receiving pharmacologic thromboprophylaxis, adjunct intermittent pneumatic compression (IPC) had no effect on the rates of lower-limb deep vein thrombosis (DVT), according to a new trial.
Eighty-four percent of the patients were diagnosed with VTE before or after the 6-week postoperative window when thromboprophylaxis typically is recommended, and 31% developed clots during chemotherapy, the investigators reported.
Thromboprophylaxis is not recommended in patients undergoing elective laparoscopic cholecystectomy without any risk factors of DVT.
Additional means of thromboprophylaxis in stroke include mechanical methods such as pneumatic compression device to prevent venous stasis and chemoprophylaxis including antiplatelets, heparins, and heparinoids.
Moreover, due to the high risk of PE, thromboprophylaxis has been used as an important treatment for hospitalized patients with COPD exacerbation.
Other study stated that AF patients at high risk for stroke and with less susceptibility for bleeding who are received inadequate levels of thromboprophylaxis treatment need great effort by different health-care sectors to evaluate and assess their treatment pattern and measure the net clinical benefit of the therapy outcomes.
Use of the CHA2DS2-VASc and HAS-BLED scores to aid decision making for thromboprophylaxis in nonvalvular atrial fibrillation.